← Back to Patent Explorer
US5512677A Expired / Lapsed US ⏱️ 0.0 years remaining

3-substituted methyl-2,3-dihydroimidazo 1,2-c!quinazoline derivatives, the preparation and use thereof

Assignee: National Science and Technology Council
•
Filing: 1994-07-20
•
Granted: 1996-04-30
•
Expires: 2014-07-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides a novel series of 3-substituted methyl-2,5-dihydroimidazo[1,2-c]quinazoline compounds. These compounds are found useful as an active ingredient for the treatment of hypertension and dysuria.

Inventors

  • 👤 Ji-Wang Chern
  • 👤 Guan-Yu Lu
  • 👤 Yue-Jun Lai
  • 👤 Mao-Hsiung Yen
  • 👤 Pao-Luh Tao

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 16:53
CPC Classifications
C; C07; C07D; C07D487/00; C07D487/02; C07D487/04

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 29 words
An imidazo 1,2-c!quinazoline compound or a pharmaceutically acceptable salt thereof selected from the group consisting of: 3-{4- 1-(2-methoxyphenyl)piperazinyl!}methyl-2,3-dihydroimidazo 1,2-c!quinazolin-5(6H)-one; 3-{4- 1-(2-chlorophenyl)piperazinyl!}methyl-2,3-dihydroimidazo 1,2-c!quinazolin-5(6H)-one; 3-{4- 1-(2-chlorophenyl)piperazinyl!}methyl-6-methyl-2,3-dihydroimidazo 1,2-c!quinazolin-5(6H)-one; and 3-{4- 1-(2-methoxyphenyl)piperazinyl!}methyl-6-methyl-2,3-dihydroimidazo 1,2-c!quinazolin-5(6H)-one.
Claim 2
Dependent Claim 29 words
An imidazo 1,2-c!quinazoline compound or a pharmaceutically acceptable salt thereof selected from the group consisting of: 3-{4- 1-(2-methoxyphenyl)piperazinyl!}methyl-2,3-dihydroimidazo 1,2-c!quinazolin-5(6H)-one; 3-{4- 1-(2-chlorophenyl)piperazinyl!}methyl-2,3-dihydroimidazo 1,2-c!quinazolin-5(6H)-one; 3-{4- 1-(2-chlorophenyl)piperazinyl!}methyl-6-methyl-2,3-dihydroimidazo 1,2-c!quinazolin-5(6H)-one; and 3-{4- 1-(2-methoxyphenyl)piperazinyl!}methyl-6-methyl-2,3-dihydroimidazo 1,2-c!quinazolin-5(6H)-one.

References Cited (Backward Citations)

US5120736A Cited
US5128338A Cited
US5158953A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-04-30 1999-10-30 2000-04-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-04-30 2003-10-30 2004-04-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-04-30 2007-10-30 2008-04-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag